首页> 外文期刊>Neuroscience: An International Journal under the Editorial Direction of IBRO >Reduction of GABA-mediated inhibitory postsynaptic potentials in hippocampal CA1 pyramidal neurons following oral flurazepam administration.
【24h】

Reduction of GABA-mediated inhibitory postsynaptic potentials in hippocampal CA1 pyramidal neurons following oral flurazepam administration.

机译:口服氟拉西m后海马CA1锥体神经元GABA介导的抑制性突触后电位的降低。

获取原文
获取原文并翻译 | 示例
           

摘要

Oral administration of the benzodiazepine, flurazepam, for one week results in tolerance in vivo and in vitro and in a reduction in recurrent and feedforward inhibition in vitro in the CA1 pyramidal cell region of hippocampus. In the present study CA1 pyramidal cells were examined intracellularly in vitro in rat hippocampal slices (500 microns) from rats sacrificed two or seven days after cessation of oral flurazepam treatment. Following drug treatment, the membrane characteristics of CA1 pyramidal cells were not significantly different from control neurons. GABAA-mediated, early inhibitory postsynaptic potentials were significantly reduced in amplitude (60%) in pyramidal neurons from rats killed two days, but not in those killed seven days, after the end of drug administration. The decrease in early inhibitory postsynaptic potential amplitude was observed using just-subthreshold, threshold and supramaximal orthodromic stimulation as well as following antidromic activation. The magnitude of the decrease in the early inhibitory postsynaptic potential amplitude was similar in the presence of the GABAB antagonist, CGP 35348, and could not be attributed to differences in the strength of afferent stimulation between flurazepam-treated and control groups. The size of the GABAB-mediated, late inhibitory postsynaptic potentials was also significantly decreased (45%) in comparison to control cells. Reversal potentials for both the early (-72 mV) and late (-92 mV) hyperpolarizations were not significantly different between groups. Following high intensity orthodromic stimulation, in the presence of an intracellular sodium channel blocker (QX-314) which also blocks the GABAB-mediated late hyperpolarization, a bicuculline-sensitive late depolarizing potential was unmasked in neurons from FZP-treated rats, but never from control cells. Excitatory postsynaptic potential amplitude was significantly increased in flurazepam-treated neurons and the threshold for the synaptically-evoked action potential was significantly increased. Following depolarizing current injection, the duration and frequency of pyramidal cell discharges and the action potential threshold were not altered by oral flurazepam treatment. The amplitude of the fast afterhyperpolarization was also not changed. Overall, the findings indicate an impairment of transmission at GABAergic synapses onto hippocampal CA1 pyramidal cell neurons after chronic benzodiazepine treatment at a time when rats are tolerant to the anticonvulsant effects of the benzodiazepines in vivo.
机译:口服苯二氮卓类药物氟拉西one持续一周,可导致体内和体外耐受,并减少海马CA1锥体细胞区域的体外复发和前馈抑制。在本研究中,在停止口服氟氮西m治疗后两到七天处死的大鼠海马切片(500微米)中,在细胞内体外检查了CA1锥体细胞。药物治疗后,CA1锥体细胞的膜特征与对照神经元无显着差异。在给药结束后,杀死2天的大鼠的锥体神经元的GABAA介导的早期抑制性突触后电位的幅度显着降低(60%),但在杀死7天的大鼠的锥体神经元中没有降低。使用正阈值以下,阈值和超最大正畸刺激以及随后的反峰激活观察到了早期抑制性突触后电位幅度的降低。在存在GABAB拮抗剂CGP 35348的情况下,早期抑制性突触后电位幅度的下降幅度相似,并且不能归因于氟西西m治疗组与对照组之间传入刺激强度的差异。与对照细胞相比,GABA B介导的晚期抑制性突触后电位的大小也显着降低(45%)。两组之间早期(-72 mV)和晚期(-92 mV)超极化的反转电位没有显着差异。在高强度的正畸刺激下,在细胞内钠通道阻滞剂(QX-314)也会阻断GABAB介导的晚期超极化的情况下,在FZP处理的大鼠的神经元中,双小分子敏感的晚期去极化潜力被揭示,但从未控制细胞。在氟西epa治疗的神经元中,兴奋性突触后电位的幅度明显增加,而突触诱发动作电位的阈值则显着增加。注射去极化电流后,口服氟拉西m治疗未改变锥体细胞放电的持续时间和频率以及动作电位阈值。快速超极化后的幅度也没有改变。总体而言,这些发现表明,在慢性苯二氮卓类药物治疗后,大鼠耐受体内苯二氮卓类药物的抗惊厥作用时,GABA能突触向海马CA1锥体细胞神经元的传递受到损害。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号